Subgroup analyses revealed significant positive correlations between plasma level of CTRP1 and FBG in three patient groups, however correlations between plasma level of CTRP1 and liver stiffness was only observed in NAFLD group (Spearman Rho = 0.521; p = 0.011) and there was not a significant correlation between plasma level of CTRP1 and other parameters in subgroups. The gene discussed is C1QTNF1; the disease is metabolic dysfunction-associated steatotic liver disease.